Literature DB >> 8613694

The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice.

G Fantuzzi1, C A Dinarello.   

Abstract

Interleukin-1 (IL-1) plays a crucial role in the development of the pathophysiological responses to infection and inflammation. However, the relative contributions of IL-1 alpha and IL-1 beta remain to be clarified. IL-1 beta-deficient mice are a powerful tool to investigate the specific role of IL-1 beta in various experimental conditions. In this report, we summarize the response of IL-1 beta deficient mice to two different inflammatory stimuli, turpentine and endotoxin. Although IL-1 beta-deficient mice respond normally to the systemic administration of lipopolysaccharide (LPS), they do not develop an acute-phase response in the localized tissue damage model of turpentine injection. The results obtained using the IL-1 beta-deficient mice are compared here with those observed in the IL-1 beta-converting enzyme-deficient, IL-6-deficient, tumour necrosis factor-receptor p55-deficient, and interferon-gamma-receptor-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613694     DOI: 10.1002/jlb.59.4.489

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

Review 1.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo.

Authors:  B Weinhold; A Bader; V Poli; U Rüther
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

Review 3.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

4.  An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia.

Authors:  N Laflamme; S Lacroix; S Rivest
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 5.  The emerging role of interleukin-1β in autoinflammatory diseases.

Authors:  Thirusha Lane; Helen J Lachmann
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

6.  Plasma cytokines associated with febrile status epilepticus in children: A potential biomarker for acute hippocampal injury.

Authors:  William B Gallentine; Shlomo Shinnar; Dale C Hesdorffer; Leon Epstein; Douglas R Nordli; Darrell V Lewis; L Matthew Frank; Syndi Seinfeld; Ruth C Shinnar; Karen Cornett; Binyi Liu; Solomon L Moshé; Shumei Sun
Journal:  Epilepsia       Date:  2017-04-27       Impact factor: 5.864

7.  IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide.

Authors:  Suhas G Kallapur; Ilias Nitsos; Timothy J M Moss; Graeme R Polglase; J Jane Pillow; Fook-Choe Cheah; Boris W Kramer; John P Newnham; Machiko Ikegami; Alan H Jobe
Journal:  Am J Respir Crit Care Med       Date:  2009-02-20       Impact factor: 21.405

Review 8.  Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Authors:  Assaf Menachem; Joab Chapman; Yael Deri; Chaim G Pick; Aviva Katzav
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

9.  Cytokine and chemokine responses of lung exposed to surrogate viral and bacterial infections.

Authors:  Teresa A Liberati; Rita A Trammell; Michelle Randle; Sarah Barrett; Linda A Toth
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

Review 10.  IL-1beta processing in host defense: beyond the inflammasomes.

Authors:  Mihai G Netea; Anna Simon; Frank van de Veerdonk; Bart-Jan Kullberg; Jos W M Van der Meer; Leo A B Joosten
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.